MedTrace Logo

Thoracic Paravertebral Block for Postoperative Pain Management After VATS

NCT06689358 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 81

Last updated 2024-11-14

No results posted yet for this study

Summary

This randomized controlled trial evaluated the efficacy of a thoracic paravertebral block (TPVB) in reducing opioid requirements and pain intensity in the PACU after video-assisted thoracoscopic surgery (VATS).

Conditions

  • Pain, Postoperative

Interventions

DRUG

0.4 ml/kg of 0.5% bupivacaine

0.4 ml/kg of 0.5% bupivacaine injected into the thoracic paravertebral space

Sponsors & Collaborators

  • King Hussein Cancer Center

    lead OTHER

Principal Investigators

  • Ahed Al-Edwan, MD · KHCC

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-11-01
Primary Completion
2024-08-01
Completion
2024-08-01

Countries

  • Jordan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06689358 on ClinicalTrials.gov